Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma.
Journal: Cancer
Published: February 18, 2019
Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: February 03, 2018
Showing 1-2 of 2
Last Updated: 09/26/2026